TG THERAPEUTICS, INC. Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31)
TG THERAPEUTICS, INC. (TGTX) reported Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) of $39.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Balance Sheet › Assets
us-gaap:HeldToMaturitySecuritiesUnrecognizedHoldingLosses · last filed 2018-05-10
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $39.00K, a 642.15% increase year-over-year.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for the quarter ending 2017-06-30 was -$2.25K.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $5.25K, a 25.13% decline year-over-year.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $2.49K, a 97.71% decline year-over-year.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for fiscal 2016 was $2.49K, a 97.71% decline from fiscal 2015.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for fiscal 2015 was $108.67K, a 1771.65% increase from fiscal 2014.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for fiscal 2014 was $5.81K, a 793.23% increase from fiscal 2013.
- TG THERAPEUTICS, INC. held-to-maturity securities, unrecognized holding loss (deprecated 2018-01-31) for fiscal 2013 was $650.00.
| Period end | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) 3 month | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) 6 month | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) 9 month | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) 12 month | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | $39.00K 10-Q · filed 2018-05-10 | ||||
| 2017-12-31 | $35.00K 10-Q · filed 2018-05-10 | $35.23K 10-K · filed 2018-03-15 | |||
| 2017-06-30 | -$2.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.00K 10-Q · filed 2017-08-09 | $5.50K derived: sum of 3 quarters · filed 2018-03-15 | $5.50K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2017-03-31 | $5.25K 10-Q · filed 2017-05-10 | $7.75K derived: sum of 2 quarters · filed 2018-03-15 | $7.75K derived: sum of 3 quarters · filed 2018-03-15 | $728.00 derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-12-31 | $2.49K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.49K derived: sum of 2 quarters · filed 2018-03-15 | -$4.53K derived: sum of 3 quarters · filed 2018-03-15 | $2.49K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$7.02K derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | $108.59K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2016-06-30 | -$7.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $108.59K derived: sum of 3 quarters · filed 2017-03-16 | $106.87K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2016-03-31 | $7.02K 10-Q · filed 2016-05-10 | $115.61K derived: sum of 2 quarters · filed 2017-03-16 | $113.89K derived: sum of 3 quarters · filed 2017-03-16 | ||
| 2015-12-31 | $108.59K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $106.87K derived: sum of 2 quarters · filed 2017-03-16 | $108.67K 10-K · filed 2017-03-16 | ||
| 2015-09-30 | -$1.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $80.00 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | $1.80K 10-Q · filed 2015-08-10 | ||||
| 2014-12-31 | $5.81K 10-K · filed 2016-03-15 | ||||
| 2013-12-31 | $650.00 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |